Nunthasiri Wittayanakorn, Georgia M Wong, Saige A Teti, Veronica D Linan-Martinez, Haris Qamar, Nathan T Cohen, William D Gaillard, Chima O Oluigbo
{"title":"Outcomes of reoperation following failed laser ablation surgery for epilepsy in pediatric patients.","authors":"Nunthasiri Wittayanakorn, Georgia M Wong, Saige A Teti, Veronica D Linan-Martinez, Haris Qamar, Nathan T Cohen, William D Gaillard, Chima O Oluigbo","doi":"10.3171/2024.11.PEDS24410","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>There are significant challenges in the surgical management of pharmacoresistant epilepsy. Laser interstitial thermal therapy (LITT) has emerged as a less invasive alternative to resection. However, seizure persistence or recurrence following LITT is not uncommon, and there is currently a lack of guidance and consensus on the best way to manage seizure recurrence after LITT for different epilepsy etiologies in children, or for the use of LITT when open resection has left residual epileptogenic tissue. The objective of this study was to assess the outcomes of secondary epilepsy surgery after failed initial LITT.</p><p><strong>Methods: </strong>The authors performed a retrospective chart review of patients who underwent secondary epilepsy surgery after failed LITT at Children's National Hospital.</p><p><strong>Results: </strong>A total of 36 patients were treated with LITT, and 4 were excluded due to the palliative purpose of LITT. Thirteen of 32 patients (40.6.%) achieved Engel I, 1 patient (3.1%) achieved Engel II, and 18 patients (56.2%) had poor outcomes (Engel III-IV). Of these 32 patients, 9 (28.1%) underwent reoperation after their first laser ablation surgery due to a recurrence of epilepsy. Seven patients had a second laser ablation, and 2 patients underwent open resection. Of these 9 patients, 3 (33.3%) had Engel I outcomes, and 6 (66.7%) had poor seizure outcomes (Engel III-IV). When considering only patients who had repeat LITT for reoperation, 2 of 7 (28.6%) of these patients achieved seizure freedom (Engel I). Of the 32 patients, short-term complications were transient oculomotor (n = 1, 3.1%) or trochlear (n = 1, 3.1%) nerve deficit, which entirely resolved within 6 months, and superior quadrantanopia (n = 1, 3.1%) after initial LITT.</p><p><strong>Conclusions: </strong>Although LITT has shown promising results in treating pharmacoresistant epilepsy, the recurrence of seizures necessitates further evaluation and consideration of reoperation, which may result in seizure freedom. Repeat LITT is a low-risk option for secondary surgery after seizure recurrence.</p>","PeriodicalId":16549,"journal":{"name":"Journal of neurosurgery. Pediatrics","volume":" ","pages":"1-10"},"PeriodicalIF":2.1000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neurosurgery. Pediatrics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3171/2024.11.PEDS24410","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:药物耐药性癫痫的手术治疗面临巨大挑战。激光间质热疗(LITT)已成为切除术的一种微创替代方法。然而,激光间质热疗后癫痫持续或复发的情况并不少见,目前对于针对不同癫痫病因的儿童激光间质热疗后癫痫复发的最佳治疗方法,或在开放性切除术后残留致痫组织时使用激光间质热疗的方法还缺乏指导和共识。本研究旨在评估初次 LITT 失败后进行二次癫痫手术的结果:作者对国立儿童医院 LITT 失败后接受二次癫痫手术的患者进行了回顾性病历审查:结果:共有36名患者接受了LITT治疗,其中4名患者因LITT的姑息性目的而被排除在外。32名患者中有13名(40.6.0%)达到了恩格尔Ⅰ级,1名(3.1%)达到了恩格尔Ⅱ级,18名(56.2%)效果不佳(恩格尔Ⅲ-Ⅳ级)。在这 32 名患者中,有 9 人(28.1%)在第一次激光消融手术后因癫痫复发而接受了再次手术。7 名患者接受了第二次激光消融手术,2 名患者接受了开放性切除手术。在这 9 名患者中,3 人(33.3%)的癫痫发作结果为恩格尔Ⅰ型,6 人(66.7%)的癫痫发作结果较差(恩格尔Ⅲ-Ⅳ型)。如果只考虑重复 LITT 再次手术的患者,7 名患者中有 2 名(28.6%)实现了癫痫发作自由(Engel I)。在 32 名患者中,首次 LITT 后出现的短期并发症是一过性眼球运动神经缺损(1 例,3.1%)或耳蜗神经缺损(1 例,3.1%),但在 6 个月内完全消失,以及上象限视力障碍(1 例,3.1%):结论:尽管LITT在治疗药物耐药性癫痫方面效果显著,但癫痫复发需要进一步评估并考虑再次手术,这样可能会使癫痫不再发作。重复 LITT 是癫痫复发后进行二次手术的低风险选择。
Outcomes of reoperation following failed laser ablation surgery for epilepsy in pediatric patients.
Objective: There are significant challenges in the surgical management of pharmacoresistant epilepsy. Laser interstitial thermal therapy (LITT) has emerged as a less invasive alternative to resection. However, seizure persistence or recurrence following LITT is not uncommon, and there is currently a lack of guidance and consensus on the best way to manage seizure recurrence after LITT for different epilepsy etiologies in children, or for the use of LITT when open resection has left residual epileptogenic tissue. The objective of this study was to assess the outcomes of secondary epilepsy surgery after failed initial LITT.
Methods: The authors performed a retrospective chart review of patients who underwent secondary epilepsy surgery after failed LITT at Children's National Hospital.
Results: A total of 36 patients were treated with LITT, and 4 were excluded due to the palliative purpose of LITT. Thirteen of 32 patients (40.6.%) achieved Engel I, 1 patient (3.1%) achieved Engel II, and 18 patients (56.2%) had poor outcomes (Engel III-IV). Of these 32 patients, 9 (28.1%) underwent reoperation after their first laser ablation surgery due to a recurrence of epilepsy. Seven patients had a second laser ablation, and 2 patients underwent open resection. Of these 9 patients, 3 (33.3%) had Engel I outcomes, and 6 (66.7%) had poor seizure outcomes (Engel III-IV). When considering only patients who had repeat LITT for reoperation, 2 of 7 (28.6%) of these patients achieved seizure freedom (Engel I). Of the 32 patients, short-term complications were transient oculomotor (n = 1, 3.1%) or trochlear (n = 1, 3.1%) nerve deficit, which entirely resolved within 6 months, and superior quadrantanopia (n = 1, 3.1%) after initial LITT.
Conclusions: Although LITT has shown promising results in treating pharmacoresistant epilepsy, the recurrence of seizures necessitates further evaluation and consideration of reoperation, which may result in seizure freedom. Repeat LITT is a low-risk option for secondary surgery after seizure recurrence.